Skip to main navigation Skip to search Skip to main content

Covid-19 Clinical Research: Pfizer/Greenphire: A Phase 2/3, Interventional Safety, Pharmacokinetics, and Efficacy, Open-Label, Multi-Center, Single-Arm Study to Investigate Orally Administered PF-07321332 (Nirmatrelvir)/Ritonavir in...

Project: Research

Project Details

StatusFinished
Effective start/end date03/17/2201/23/25

Funding

  • Parexel International LLC: $18,175.18